Clarifying the pathogenesis of chronic hepatitis C through comprehensive genetic analyses of the virus and host using next-generation sequencer
Clarifying the pathogenesis of chronic hepatitis C through comprehensive genetic analyses of the virus and host using next-generation sequencer
批准号:
23390195
负责人:
ENOMOTO Nobuyuki
金额:
$12.4万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-04-01 至 2014-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Hepatitis C virus has been considered to exist in a host as a complex mixture of various viral mutant subpopulations called as "quasispecies". However, analyzing viral quasispecies and its role in the pathogenesis of hepatitis has been difficult due to the technical limitation. In this study, through introducing the revolutionary technology of next-generation sequencing, we disclosed that the quasispecies state and its dynamics had a significant association with antiviral therapies as well as hepatocarcinogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s00330-012-2571-6
发表时间:
2013-01-01
期刊:
EUROPEAN RADIOLOGY
影响因子:
5.9
作者:
[Motosugi, Utaroh, Ichikawa, Tomoaki, Araki, Tsutomu]
通讯作者:
Araki, Tsutomu
DOI:
10.1371/journal.pone.0082299
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Shen H, Yamashita A, Nakakoshi M, Yokoe H, Sudo M, Kasai H, Tanaka T, Fujimoto Y, Ikeda M, Kato N, Sakamoto N, Shindo H, Maekawa S, Enomoto N, Tsubuki M, Moriishi K]
通讯作者:
Moriishi K
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma.
索拉非尼施用后8周,血浆血管内皮生长因子的变化是晚期肝细胞癌生存的预测指标。
DOI:
10.1002/cncr.28384
发表时间:
2014-01-15
期刊:
CANCER
影响因子:
6.2
作者:
[Tsuchiya, Kaoru, Asahina, Yasuhiro, Matsuda, Shuya, Muraoka, Masaru, Nakata, Toru, Suzuki, Yuichiro, Tamaki, Nobuharu, Yasui, Yutaka, Suzuki, Shoko, Hosokawa, Takanori, Nishimura, Takashi, Ueda, Ken, Kuzuya, Teiji, Nakanishi, Hiroyuki, Itakura, Jun, Takahashi, Yuka, Kurosaki, Masayuki, Enomoto, Nobuyuki, Izumi, Namiki]
通讯作者:
Izumi, Namiki
A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors
诱导拟合对接新方法(GENIUS)及其在新型HCV NS3-4A蛋白酶抑制剂虚拟筛选中的应用
DOI:
10.1016/j.bmc.2011.09.023
发表时间:
2011
期刊:
Bioorganic & Medicinal Chemistry
影响因子:
3.5
作者:
[Takaya D, Sakamoto N, et al.]
通讯作者:
et al.
RETRY Study Group. Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy
RETRY 研究组。对先前聚乙二醇干扰素 α-2b + 利巴韦林联合治疗失败的患者进行聚乙二醇干扰素 α-2a + 利巴韦林再治疗
DOI:
--
发表时间:
2012
期刊:
Dig Dis
影响因子:
--
作者:
[Ueda T, Tsuchiya K, Hashimoto S, Inoue T, Enomoto N, Inao M, Tanaka A, Kaito M, Imazeki F, Nishiguchi S, Mochida S, Yokosuka O, Yatsuhashi H, Izumi N, Kudo M]
通讯作者:
Kudo M
共 34 条
Next-generation sequence of cancer-related genes in digestive organ cancers using clinical samples
-
批准号:26670380
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Analysis ofchronic viral hepaptis by the large-scale next generation sequeincing
-
批准号:21659186
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.11万
-
财政年份:2009
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Comprehensive analysis of chronic hepatitis C by large-scale viral genome wide analysis
-
批准号:20390206
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2008
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Analysis of anti-interferon mechanism by HCV NS5A protein using HCV replicon system
-
批准号:14370175
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2002
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Development of anti-HCV therapy the regulation of NS5A function
-
批准号:12557053
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:2000
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Analysis of liver diesease related gene expression using subtraction cloning
-
批准号:12670467
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Function of HCV NS5A protein and the mechanism of interferon resistance
-
批准号:10670456
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1998
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
Elucidation of Interferon Sensitivity Determining Region in Hepatitis C Virus Genome
-
批准号:06670525
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1994
-
负责人:ENOMOTO Nobuyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
UDCA抑制G6PD活性诱导 HCC 细胞铁死亡的抗肝癌机制研究
-
批准号:2026JJ82280
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:熊玉婕
-
依托单位:
NAFLD-HCC中去泛素化酶USP45稳定HK2促进糖酵解调控HCC细胞干性增殖功能的机制研究
-
批准号:2026JJ80512
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘子儒
-
依托单位:
Wnt β-连环蛋白信号介导的肿瘤微环境免疫细胞浸润影响缺血再灌注损伤后HCC复发的作用机制研究
-
批准号:2026JJ82621
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:余加
-
依托单位:
黄芪-莪术调控组氨酸代谢改善 DCs 功能与 Th1极化重塑 HCC 免疫微环境的机制研究
-
批准号:ZCLMS26H2802
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱智慧
-
依托单位:
特征指标联合和多源数据融合提升肝细胞癌(HCC)疾病基因预测能力的研究
-
批准号:2026JJ81246
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:高媛媛
-
依托单位:
HSP27在TPL促进HCC凋亡、延缓肿瘤转移及侵袭的机制研究
-
批准号:2026JJ81585
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周淑华
-
依托单位:
B3GAT3介导CDK4蛋白糖基化修饰促进肝癌细胞衰老抵抗与HCC发生发展的机制与转化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
IGF2BP2/hnRNPU调控SREBP-1可变剪接促进MASH-HCC发生的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:聂丹
-
依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
-
批准号:JCZRQN202500319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
侵袭亚型HCC多组学融合预后模型构建及术后辅助免疫治疗疗效预测
-
批准号:2025JJ60750
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赵一珺
-
依托单位: